《Pharmacology Research & Perspectives》雜志的最新年發(fā)文量為104篇。
這表明該刊在每年都會精選并發(fā)表一定數(shù)量的高質(zhì)量文章，以保持其在藥學(xué)領(lǐng)域的學(xué)術(shù)影響力。
該刊聚焦于醫(yī)學(xué)-藥學(xué)領(lǐng)域的前沿研究，致力于推動該領(lǐng)域新技術(shù)和新知識的傳播與應(yīng)用。同時它積極鼓勵研究人員詳細(xì)發(fā)表其高質(zhì)量的實(shí)驗(yàn)研究和理論成果。
該刊的平均審稿周期約為 20 Weeks 。
Pharmacology Research & Perspectives 雜志發(fā)文統(tǒng)計(jì)
文章名稱引用次數(shù)
- Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs21
- Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease20
- Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc(-)12
- Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations11
- MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential10
- Revisiting the putative role of heme as a trigger of inflammation10
- Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues9
- The safety, tolerability, and pharmacokinetic profile of GSK283 a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects8
- Depressive disorders: Treatment failures and poor prognosis over the last 50 years8
- The sodium pump and digitalis drugs: Dogmas and fallacies8
國家/地區(qū)發(fā)文量
- USA110
- Japan40
- England28
- Australia20
- GERMANY (FED REP GER)17
- Netherlands16
- Canada15
- Switzerland15
- CHINA MAINLAND13
- France13
